Verona Pharma price target raised to $77 from $51 at BTIG

6 days ago · BTIG raised the firm’s price target on Verona Pharma (VRNA) to $77 from $51 and keeps a Buy rating on the shares. The company’s Q4 pre-announcement was "impressive", …

$77
OFF

Verona Pharma Price Target Raised To $77 From $51 At BTIG

2 weeks from now

6 days ago · BTIG raised the firm’s price target on Verona Pharma (VRNA) to $77 from $51 and keeps a Buy rating on the shares. The company’s Q4 pre-announcement was "impressive", …

nasdaq.com

$74
OFF

Verona Pharma’s Ohtuvayre: Unique COPD Solution ... - Markets …

2 weeks from now

5 days ago · Verona Pharma price target raised to $74 from $64 at Wells Fargo Verona Pharma price target raised to $77 from $51 at BTIG Verona Pharma sees Q4 net product sales …

businessinsider.com

$77
OFF

Verona Pharma Stock Target Raised To $77 At BTIG

2 weeks from now

Jan 7, 2025 · In other recent news, Verona Pharma (NASDAQ: VRNA) has reported positive financial developments, including preliminary fourth-quarter sales that exceeded expectations …

investing.com

$77
OFF

Verona Pharma Stock Target Raised To $77 At BTIG - Investing.com …

2 weeks from now

In other recent news, Verona Pharma (NASDAQ: VRNA) has reported positive financial developments, including preliminary fourth-quarter sales that exceeded expectations and a …

investing.com

$74
OFF

Verona Pharma Initiated With A Buy At Roth MKM - Markets Insider

2 weeks from now

5 days ago · Verona Pharma price target raised to $74 from $64 at Wells Fargo Verona Pharma price target raised to $77 from $51 at BTIG Verona Pharma sees Q4 net product sales …

businessinsider.com

$77
OFF

VRNA News Today | Why Did Verona Pharma Stock Go Down …

2 weeks from now

5 days ago · What's going on at Verona Pharma (NASDAQ:VRNA)? Read today's VRNA news from trusted media outlets at MarketBeat. ... Verona Pharma price target raised to $77 from …

marketbeat.com

$77
OFF

Verona Pharma Stock Target Raised To $77 At BTIG - Investing.com

2 weeks from now

Jan 7, 2025 · Verona Pharma stock target raised to $77 at BTIG. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing …

investing.com

$74
OFF

Verona Pharma Price Target Raised To $74 From $64 At Wells Fargo

2 weeks from now

6 days ago · Try Now>>See Insiders’ Hot Stocks on TipRanks >> Read More on VRNA:Verona Pharma price target raised to $77 from $51 at BTIGVerona Pharma sees Q4 net product sales …

nasdaq.com

$42
OFF

Verona Pharma (NASDAQ:VRNA) Stock, Analyst Ratings, Price …

2 weeks from now

Verona Pharma PLC has a consensus price target of $42 based on the ratings of 7 analysts. The high is $64 issued by Wells Fargo on November 5, 2024 . The low is $31 issued by BTIG on …

benzinga.com

$77
OFF

Verona Pharma Stock Target Raised To $77 At BTIG

2 weeks from now

Jan 7, 2025 · In other recent news, Verona Pharma (NASDAQ: VRNA) has reported positive financial developments, including preliminary fourth-quarter sales that exceeded expectations …

investing.com

$74
OFF

Verona Pharma Price Target Raised To $74 From $64 At Wells Fargo

2 weeks from now

Jan 8, 2025 · Wells Fargo analyst Tiago Fauth raised the firm’s price target on Verona Pharma to $74 from $64 and keeps an Overweight rating on the shares.The firm notes preliminary Q4 …

businessinsider.com

$77
OFF

Verona Pharma (VRNA) PT Raised To $77 At BTIG - Streetinsider.com

2 weeks from now

Jan 7, 2025 · BTIG analyst Thomas Shrader raised the price target on Verona Pharma (NASDAQ: VRNA) to $77.00 (from $51.00) while maintaining a ... This is a premium only article.

streetinsider.com

$44
OFF

Verona Pharma Management To Meet With BTIG | Nasdaq

2 weeks from now

Nov 6, 2024 · Verona Pharma price target raised to $44 from $37 at Canaccord; Verona Pharma price target raised to $42 from $36 at H.C. Wainwright; Verona Pharma Faces Financial Risks …

nasdaq.com

$46.24
OFF

Verona Pharma Stock Price | VRNA Stock Quote, News, And …

2 weeks from now

6 days ago · On Wednesday 01/08/2025 the closing price of the Verona Pharma PLC (spons. ADRs) share was $46.24 on BTT. Compared to the opening price on Wednesday 01/08/2025 …

businessinsider.com

$74.00
OFF

Verona Pharma (NASDAQ:VRNA) Price Target Raised To $74.00

2 weeks from now

5 days ago · Read Verona Pharma (NASDAQ:VRNA) Price Target Raised to $74.00 at ETF Daily News ... Verona Pharma has a 1-year low of $11.39 and a 1-year high of $51.80. The …

etfdailynews.com

$57
OFF

Verona Pharma Price Target Raised To $57 From $44 At Truist

2 weeks from now

6 days ago · Truist raised the firm’s price target on Verona Pharma (VRNA) to $57 from $44 and keeps a Buy rating on the shares. The firm cites the company’s positive Q4 revenue pre …

nasdaq.com

$50.57
OFF

Verona Pharma (VRNA) Stock Forecast And Price Target 2025

2 weeks from now

5 days ago · According to the 8 analysts' twelve-month price targets for Verona Pharma, the average price target is $50.57. The highest price target for VRNA is $74.00, while the lowest …

marketbeat.com

FAQs about Verona Pharma price target raised to $77 from $51 at BTIG Coupon?

Is Verona Pharma (vRNA) a good stock to buy?

Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price target raised by investment analysts at Wells Fargo & Company from $64.00 to $74.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. ...

What was Verona Pharma's stock price on January 1st 2024?

Verona Pharma's stock was trading at $19.88 on January 1st, 2024. Since then, VRNA shares have increased by 114.7% and is now trading at $42.68. How were Verona Pharma's earnings last quarter? Verona Pharma plc (NASDAQ:VRNA) issued its earnings results on Monday, November, 4th. ...

When did Verona Pharma IPO?

Verona Pharma (VRNA) raised $61 million in an initial public offering (IPO) on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel served as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers. ...

How much did Verona Pharma plc (spons ADRs) share cost on BTT?

Discover the best brokers for stock trading and ordering other assets! On Wednesday 01/08/2025 the closing price of the Verona Pharma PLC (spons. ADRs) share was $46.24 on BTT. Compared to the opening price on Wednesday 01/08/2025 on BTT of $0.00, this is a gain of 100.00%. ...

Is Verona Pharma (vRNA) a sustainable investment?

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable Zacks Equity Research Fri, Jan 10, 2025, 5:50 AM3 min read In This Article: VRNA When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. ...

Does Mirae own Verona Pharma?

Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Verona Pharma by 25.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,610 shares of the company’s stock valued at $75,000 after purchasing an additional 529 shares in the last quarter. ...